Jefferies investment banker Chris Roop discussed the Big Pharma M&A outlook with Business Insider. Check out the types of ...

Pharmaceutical companies are raising the price of over 250 brand drugs this year. Nearly all the price increases are under 10 ...

Overall, biopharma layoffs rose ever so slightly in 2024 compared to the year before, though the number of layoff rounds ...

Several large drugmakers, including Pfizer, Bristol Myers Squibb and Sanofi, increased the list prices of their drugs this ...

Stock market giants including Nvidia and Walmart completed stock splits in 2024. Investors like these operations because they ...

A mental health epidemic among the young, with over half of those under 30 struggling with significant mental health issues, ...

From PBMs to abortion, there are plenty of health policy issues that will vie for the spotlight in 2025. For pharma marketers ...

Today's changing marketplace, and increasingly competitive landscape, means that pharma companies are now competing in a whole new ball game. This is where Big Data comes in. Insights that can be ...

Here are some clinical trials that could send Big Pharma shares soaring, or crashing, in 2025. Eli Lilly. The world’s biggest ...